ClinicalTrials.Veeva

Menu

Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients (pRNA-COVID-ICU)

H

Hopital of Melun

Status

Completed

Conditions

COVID-19 Pneumonia
ARDS Due to Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2

Treatments

Diagnostic Test: plasmatic SARS-CoV-2 RNA quantification

Study type

Observational

Funder types

Other

Identifiers

NCT05115045
2021-MIR-05

Details and patient eligibility

About

Retrospective, observationnal study. Evaluation of the association between plasmatic SARS-CoV-2 RNA and day 60 mortality in ICU adult COVID-19 patients.

Enrollment

122 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age above 18 years
  • in ICU hospitalization
  • COVID-19 related pneumonia confirmed by PCR

Exclusion criteria

  • plasmatic SARS-COV-2 RNA quantification not available
  • patient's refusal to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems